Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency.
Hamblin
Terry J
TJ
D000361:Agammaglobulinemia / Q000188:drug therapy* / Q000276:immunology; D000368:Aged; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D017741:Survivors; D016896:Treatment Outcome; D014860:Warts / Q000188:drug therapy* / Q000276:immunology / Q000821:virology
D007376:Interleukin-2